Back to list

1289-0032 Study: Exploring Early Interventions for People at Risk of Psychosis

University of North Carolina at Chapel Hill


Description

Patients eligible for this study may have experienced symptoms such as: • Trouble thinking clearly or concentrating • Believing or hearing things that others do not • Losing control of your thoughts • Feeling nervous or anxious • Feeling that others are "out to get you" • Having trouble with family and friends • Having thoughts that scare you or the people around you Because you and others have experienced symptoms like these, local doctors are conducting the 1289-0032 Research Study. In this study, doctors want to evaluated the safety and effectiveness of an investigational drug and compare it to placebo, which looks like the investigational drug but contains no active medication. The investigational drug is not approved to treat any mental health or medical condition. The results of this study will provide more information about the investigational drug and whether it could one day be used to help people who have experienced symptoms similar to yours.


Keywords:

Mental Health


Category:

Drug or Biologic
Phase:2

Qualifications

 


Age
16 - 30 years


Gender
Any


Study Population

Adolescents and young adults at clinical high risk for psychosis.


Investigator

Diana Perkins
Professor
Psychiatry - Center of Excellence - Outreach and Support Intervention Services (OASIS)

For questions, contact:

Jennifer Nieri
jennifer_nieri@med.unc.edu
(877) 774-6319
Visit Website

Recruitment Period End

September 1, 2021

Location

Primary Location
UNC School of Medicine Med Wings

Study Qualifications

Gender Any

Age Range 16 - 30 years

Participant qualification(s) You may be able to particiape in this study if you: • Are 16-30 years of age • Are experiencing one or more of the symptoms listed above

Not eligible if: • Diagnosis of schizophrenia, schizophreniform, schizoaffective disorder, bipolar disorder I, or major depressive disorder with psychotic symptoms. • Currently taking clozapine.

Number of Visits

    » 15 In person visit(s)

    1 screening visit, 14 in-clinic visits involing various assessments

    » 10 Remote visit(s)

    10 phone visits involving the completion of online surveys

Participation Period

56 weeks

Compensation

Participants can earn up to $2140

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.